DK0454813T3 - Caseinfraktion til terapeutisk, profylaktisk og/eller diagnostisk anvendelse ved infektioner i åndedrætssystemet - Google Patents

Caseinfraktion til terapeutisk, profylaktisk og/eller diagnostisk anvendelse ved infektioner i åndedrætssystemet

Info

Publication number: DK0454813T3
Authority: DK; Denmark
Prior art keywords: prophylactic; respiratory tract; therapeutic; caseinfraction; diagnostic use
Prior art date: 1989-10-30

Application number

DK90916537T

Other languages

Danish (da)

English (en)

Inventor

Bengt Andersson

Gustaf Aniansson

Ragnar Lindstedt

Eden Catharina Svanborg

Original Assignee

Bengt Andersson

Gustaf Aniansson

Ragnar Lindstedt

Eden Catharina Svanborg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-30

Filing date

1990-10-30

Publication date

1999-02-01

1990-10-30 Application filed by Bengt Andersson, Gustaf Aniansson, Ragnar Lindstedt, Eden Catharina Svanborg filed Critical Bengt Andersson

1999-02-01 Application granted granted Critical

1999-02-01 Publication of DK0454813T3 publication Critical patent/DK0454813T3/da

Links

230000000069 prophylactic effect Effects 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title abstract 2
206010057190 Respiratory tract infections Diseases 0.000 title 1
208000020029 respiratory tract infectious disease Diseases 0.000 title 1
208000015181 infectious disease Diseases 0.000 abstract 2
235000013336 milk Nutrition 0.000 abstract 2
210000004080 milk Anatomy 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
241000606768 Haemophilus influenzae Species 0.000 abstract 1
239000005018 casein Substances 0.000 abstract 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
235000021240 caseins Nutrition 0.000 abstract 1
235000020256 human milk Nutrition 0.000 abstract 1
210000004251 human milk Anatomy 0.000 abstract 1
239000008267 milk Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
210000002345 respiratory system Anatomy 0.000 abstract 1
239000000758 substrate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/202—Casein or caseinates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Pulmonology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Polymers & Plastics (AREA)
Virology (AREA)
Food Science & Technology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

DK90916537T 1989-10-30 1990-10-30 Caseinfraktion til terapeutisk, profylaktisk og/eller diagnostisk anvendelse ved infektioner i åndedrætssystemet DK0454813T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE8903625A SE465109B (sv)	1989-10-30	1989-10-30	Antibakteriell komposition
PCT/SE1990/000702 WO1991006308A1 (en)	1989-10-30	1990-10-30	A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract

Publications (1)

Publication Number	Publication Date
DK0454813T3 true DK0454813T3 (da)	1999-02-01

Family

ID=20377332

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90916537T DK0454813T3 (da)	1989-10-30	1990-10-30	Caseinfraktion til terapeutisk, profylaktisk og/eller diagnostisk anvendelse ved infektioner i åndedrætssystemet

Country Status (15)

Country	Link
EP (1)	EP0454813B1 (de)
JP (1)	JPH04503077A (de)
KR (1)	KR920700678A (de)
AT (1)	ATE170754T1 (de)
AU (1)	AU633647B2 (de)
CA (1)	CA2044244A1 (de)
DE (1)	DE69032646T2 (de)
DK (1)	DK0454813T3 (de)
ES (1)	ES2121755T3 (de)
FI (1)	FI102516B (de)
HU (1)	HU212935B (de)
NO (1)	NO912391D0 (de)
RU (1)	RU2035913C1 (de)
SE (1)	SE465109B (de)
WO (1)	WO1991006308A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5538952A (en) *	1994-05-26	1996-07-23	Abbott Laboratories	Inhibition of infection of mammalian cells by respiratory syncytial virus
CA2190609A1 (en) *	1994-05-26	1995-12-07	Pradip Mukerji	Inhibition of infection of mammalian cells by respiratory syncytial virus
US5506209A (en) *	1994-05-26	1996-04-09	Abbott Laboratories	Product for inhibition of infection of mammalian cells by respiratory syncytial virus
US5707968A (en) *	1994-05-26	1998-01-13	Abbott Laboratories	Inhibition of attachment of H.influenzae to human cells
WO1995032728A1 (en) *	1994-05-26	1995-12-07	Abbott Laboratories	Inhibition of attachment of h. influenzae to human cells
US5643880A (en) *	1994-05-26	1997-07-01	Abbott Laboratories	Product for inhibition of attachment of H. influenzae to human cells
US5942254A (en) *	1995-02-27	1999-08-24	Abbott Laboratories	Phosphorylated recombinant human β-casein expressed in a bacterial system
JP2000500141A (ja) *	1995-11-06	2000-01-11	アボツト・ラボラトリーズ	リン酸化された組換えヒトベータ−カゼインを用いるヒト細胞に対するインフルエンザ菌の付着阻止方法
AU1158197A (en) *	1995-11-06	1997-08-11	Abbott Laboratories	Product for inhibition of attachment of h. influenzae to human cells
AUPP494798A0 (en)	1998-07-29	1998-08-20	Pacific Biolink Pty Limited	Protective protein formulation
BR0215954A (pt)	2002-11-26	2005-09-13	Uc Tech	Métodos de redução da possibilidade de mortalidade em um animal, de expressão virulenta em um patógeno intestinal, e da expressão de adesina / lectina pa-i em uma célula bacteriana, de inibição de expressão de adesina / lectina pa-i em um patógeno intestinal, de ativação induzida por intestino de adesina / lectina pa-i, de mudança morfológica induzida por c4-hsl de um patógeno intestinal, e de aderência de célula bacteriana em um intestino de mamìfero, de melhoria de patogênese intestinal, de prevenção de uma doença ou condição anormal, de infecção de pele e respiratória, de uma doença sexualmente transmitida, de um distúrbio de trato digestivo, de perda de capacidade lactante em um animal, e de desenvolvimento de um distúrbio epitelial mediado por micróbio em uma animal de idade de amamentação, de irrigação de pelo menos uma porção do trato urinário, e para monitoração da administração de poli (etileno-glicol) (peg) a um animal, composição farmacêutica, kits para a prevenção ou tratamento terapêutico de sepsia derivada de intestino, e para a monitoração da administração de poli (etileno-glicol), e, preservativo
RU2346694C2 (ru) *	2002-11-26	2009-02-20	Дзе Юниверсити Оф Чикаго	Вещества и способы для профилактики и лечения опосредованных микроорганизмами эпителиальных нарушений
US20110059062A1 (en) *	2007-07-06	2011-03-10	Michael A Pellico	Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1496671A (en) *	1975-03-27	1977-12-30	Grindstedvaerket As	Anti-cancer-active sour milk fraction
FR2491334A1 (fr) *	1980-10-03	1982-04-09	Inst Nat Sante Rech Med	Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2592769B1 (fr) *	1986-01-10	1990-10-12	Agronomique Inst Nat Rech	Procede d'obtention d'une matiere enrichie en caseine beta, appareillage pour la mise en oeuvre de ce procede, et application des produits obtenus par ce procede comme aliments, complements alimentaires ou additifs en industrie alimentaire et pharmaceutique ou dans la preparation de peptides a activite physiologique
JP2631470B2 (ja) *	1987-05-15	1997-07-16	雪印乳業株式会社	感染防御剤

1989
- 1989-10-30 SE SE8903625A patent/SE465109B/sv not_active IP Right Cessation
1990
- 1990-10-30 KR KR1019910700615A patent/KR920700678A/ko not_active Ceased
- 1990-10-30 HU HU912203A patent/HU212935B/hu not_active IP Right Cessation
- 1990-10-30 AT AT90916537T patent/ATE170754T1/de not_active IP Right Cessation
- 1990-10-30 ES ES90916537T patent/ES2121755T3/es not_active Expired - Lifetime
- 1990-10-30 CA CA002044244A patent/CA2044244A1/en not_active Abandoned
- 1990-10-30 WO PCT/SE1990/000702 patent/WO1991006308A1/en not_active Ceased
- 1990-10-30 EP EP90916537A patent/EP0454813B1/de not_active Expired - Lifetime
- 1990-10-30 DK DK90916537T patent/DK0454813T3/da active
- 1990-10-30 AU AU66470/90A patent/AU633647B2/en not_active Ceased
- 1990-10-30 DE DE69032646T patent/DE69032646T2/de not_active Expired - Fee Related
- 1990-10-30 JP JP2515465A patent/JPH04503077A/ja active Pending
1991
- 1991-06-19 NO NO912391A patent/NO912391D0/no unknown
- 1991-06-28 FI FI913154A patent/FI102516B/fi active
- 1991-06-28 RU SU914895868A patent/RU2035913C1/ru active

Also Published As

Publication number	Publication date
DE69032646T2 (de)	1999-05-27
WO1991006308A1 (en)	1991-05-16
EP0454813A1 (de)	1991-11-06
SE8903625D0 (sv)	1989-10-30
NO912391L (no)	1991-06-19
SE465109B (sv)	1991-07-29
FI913154A0 (fi)	1991-06-28
NO912391D0 (no)	1991-06-19
DE69032646D1 (de)	1998-10-15
CA2044244A1 (en)	1991-05-01
EP0454813B1 (de)	1998-09-09
KR920700678A (ko)	1992-08-10
FI102516B1 (fi)	1998-12-31
FI102516B (fi)	1998-12-31
JPH04503077A (ja)	1992-06-04
AU6647090A (en)	1991-05-31
ATE170754T1 (de)	1998-09-15
RU2035913C1 (ru)	1995-05-27
HU212935B (en)	1996-12-30
AU633647B2 (en)	1993-02-04
SE8903625L (sv)	1991-05-01
ES2121755T3 (es)	1998-12-16

Publication	Publication Date	Title
DK0454813T3 (da)	1999-02-01	Caseinfraktion til terapeutisk, profylaktisk og/eller diagnostisk anvendelse ved infektioner i åndedrætssystemet
EP0909814A3 (de)	2003-02-26	Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit
EP2261358A3 (de)	2011-02-23	Streptokokken-Antigene
DE3853854D1 (de)	1995-06-29	Vakzin gegen Neisseria meningitidis Gruppe-B, Gammaglobulin und Transferfaktor.
MXPA03000103A (es)	2003-06-19	Antigenos de streptococcus.
WO1999042588A3 (en)	2000-03-23	Group b streptococcus antigens
DE69636228D1 (de)	2006-07-20	Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen
ATE165395T1 (de)	1998-05-15	Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
CA2180950A1 (en)	1995-08-17	Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
EP0390799A4 (en)	1992-09-02	Respiratory syncytial virus: vaccines and diagnostic assays
EP1731166A3 (de)	2007-02-21	Streptococcus pneumoniae Proteine und Impfstoffe
Erickson et al.	1990	Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis.
ATE43500T1 (de)	1989-06-15	Herstellung von antikoerpern.
DE69419782D1 (de)	1999-09-02	Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
WO1992021697A3 (en)	1993-05-13	Diagnostic peptides derived from m.tuberculosis antigens
DE69002946D1 (de)	1993-09-30	Paracetamol enthaltende arzneizubereitung.
Di Conza	1969	Protective action of passively transferred immune serum and immunoglobulin fractions against tissue invasive stages of the dwarf tapeworm, Hymenolepis nana
Challacombe et al.	1972	Serum and salivary antibodies to glucosyltransferase in dental caries in man
DE3560262D1 (en)	1987-07-23	Hexapeptide, process for its preparation and pharmaceutical compositions thereof
FR2705234B1 (fr)	1995-08-04	Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.
Namba et al.	1986	Detection of Streptococcus hemolyticus by culturette brand 10-minute group A strep ID(strep ID) in Behcet's disease.
COCK et al.	1946	CANADIAN DOMINION DAY HONOURS The names of the following members of the medical profession
DE69016135D1 (de)	1995-03-02	Diagnostikgerät zur funktionellen Untersuchung des Kreislaufsystems.
NO20000694D0 (no)	2000-02-11	FremgangsmÕte for fremstilling av kontrastmidler som i utstrakt grad er fri for bivirkninger
MX9800191A (es)	1998-05-31	Peptidos novedosos derivados de proteina humana 60 producida por choque termico, para tratamiento de diabetes, composiciones, metodos y equipos.